A Phase II, randomized, observer-blind, controlled, age de-escalation study in approximately 140 toddlers and 700 infants in the US and Canada. This study is to asses the Safety and Immunogenicity of a Pheumococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Toddlers Infants.